Forming a network of clinicians and scientists

The Nordic AML Group (NAMLG) aims to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.

Photo: NASA

We look forward to welcoming you to Bergen for the next NAMLG meeting, September 16-18, 2026!

Find more information here.

Join us for an inspiring program filled with impactful discussions, cutting-edge insights, and the chance to connect with colleagues from across the Nordic region and beyond. We are happy to already announce a long list of confirmed distinguished speakers including:

TP53 Focus Sessions (September 17)

Shah Mithun (Mayo Clinic)

Marina Konopleva (Einstein College of Medicine)

Hussain Abbas (MD Anderson)

David Lane (Dundee/Stockholm)

Klas Wiman (Stockholm)

Jean-Cristophe Bourdon (Dundee)

Anders Myhre (Oslo)

Tor Henrik Tvedt (Oslo)

FLT3 Focus Sessions (September 18)

Marc Raaijmakers (Rotterdam)

Lars Rönnstrand (Lund)

Yngvar Fløysand (Stockholm)

Gunnar Juliusson (Lund)

In addition, we’ll again arrange an Educational Day for clinicians (September 16), this time as a joint venture with the Nordic MDS Group.

Organizing Committee

Conference Chair

Bjørn Tore Gjertsen

Scientific Organizing Committee

Sören Lehmann, Albin Österroos, Daniel Tuyet Kristensen, Pia Ettala, Marianne Tang Severinsen

Local Organizing Committee

Gro Gausdal, Reidun Kopperud

News from NAMLG

[News? Please, let us know via namlgewg@gmail.com.]

New edition of “Blodets sjukdomar”

Gösta Gahrton and Gunnar Juliusson are the editors of the Swedish-language textbook Blodets sjukdomar, which has just been released in a new, extensively revised and expanded edition. The book reflects the rapid advances in hematology – from molecular diagnostics and clonal hematopoiesis to targeted therapies and cell-based treatments.

All chapters have been thoroughly updated, and several entirely new sections have been added, covering topics such as clonal hematopoiesis, hereditary predisposition, mastocytosis, and advanced cell therapy. The book serves both as a modern introduction for physicians in training and as a practical reference for established specialists wishing to stay current with this fast-moving field.

Now available at studentlitteratur.se.